CAS No.864731-61-3 Fluranaler

Fluralaner (INN) is a systemic insecticide and acaricide that is administered orally or topically. The U.S. Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs in May 2014 and Bravecto Plus as a topical treatment for cats in November 2019, with warnings about possible side effects in both species.

Fluranaler Synonym

Fluralaner; 4-(5-(3, 5-dichlorophenyl)-5-(trifluoromethyl)-4, 5-dihydroisoxazol-3-yl)-2-methyl-N-(2-oxo-2-(2, 2, 2-trifluoroethylamino)ethyl)benzamide; 4-[(5R)-5-(3, 5-dichlorophenyl)-5-(trifluoromethyl)-4H-1, 2-oxazol-3-yl]-2-methyl-N-[2-Chemicalbookoxo-2-(2, 2, 2-trifluoroethylamino)ethyl]benzamide; A1443; AH252723; AH252723; Benzamide, 4-[5-(3, 5-dichlorophenyl)-4, 5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-[2-oxo-2-[(2, 2, 2-trifluoroethyl)amino]ethyl]-; Fluralanerfandachem

• CAS No.: 864731-61-3

• EC No.: 689-035-6

• MF: C22H17Cl2F6N3O3

• MW: 556.29